Carl Zeiss and Aaren buy, Alimera raise working capital and Novo A/S make a milestone payment to Ophthotech for Fovista.

An unexpected and simple advance has made stem cell production much easier and safer. Do STAP stem cells bring the treatment, even cure, of ocular disease a lot closer?

Be it battling blindness one patient at a time or changing global healthcare policies, ophthalmologists demonstrate admirable altruism.

Ranking the 100 most influential people in ophthalmology. Which clinicians and researchers have the biggest impact on our field?

Academic ophthalmologists are expected to be effective teachers but receive little or no instruction on teaching methodology.

For all of us associated with healthcare, it should be apparent that our world is on the cusp of a significant change.

Sitting Down With Carrie MacEwen, Consultant Ophthalmologist at Ninewells Hospital, Dundee, Scotland, and President-Elect of the UK Royal College of Ophthalmologists

A new drug, ALG-1001, that blocks the transmembrane receptors that cells use to attach to their surroundings, has the potential to treat a range of retinovascular diseases

The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?

Intracorneal ring segment and phakic IOL implantation: a refractive solution for patients with keratoconus and high myopia